Olympiad Research’s NEOPHOTONICS CORP NPTN Stock Holding History

Olympiad Research’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-133,119	Closed	-$2.09M	–	349
2022 Q2	$2.09M	Buy	133,119 +35,716	+37%	+$545K	0.94%	36
2022 Q1	$1.48M	Buy	97,403 +40,670	+72%	+$619K	0.45%	65
2021 Q4	$872K	Buy	+56,733	New	+$746K	0.32%	95
2020 Q3	–	Sell	-20,824	Closed	-$185K	–	477
2020 Q2	$185K	Buy	+20,824	New	+$180K	0.13%	229

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Olympiad Research's NPTN Position: Q3 2022 in Review

Olympiad Research sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 133,119 shares — an estimated $2.09M sold.

Olympiad Research first reported a position in NPTN in Q2 2020 and held it in 4 quarters. The position peaked at $2.09M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Olympiad Research reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Olympiad Research sold 133,119 NEOPHOTONICS CORP shares in Q3 2022, an estimated $2.09M.
Olympiad Research first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 4 quarters.
Olympiad Research's NEOPHOTONICS CORP position peaked at $2.09M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Olympiad Research's 13F filing for Q3 2022, filed 7 Nov 2022.